Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
NCT02412085
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Colitis, Ulcerative
Interventions
DRUG:
Golimumab
Sponsor
Istituto Clinico Humanitas